NCT00825734 Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00823550 Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients Status UNKNOWN Phase PHASE4
NCT00821886 Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00820170 Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 Status COMPLETED Phase PHASE1/PHASE2
NCT00816959 Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma Status UNKNOWN Phase PHASE3
NCT00814268 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Status COMPLETED Phase PHASE4
NCT00810147 A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00804310 Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00803647 A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver Status COMPLETED Phase PHASE2
NCT00803556 Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy Status COMPLETED Phase PHASE1
NCT00803374 Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma Status WITHDRAWN Phase PHASE1
NCT00799045 Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects Status COMPLETED Phase PHASE4
NCT00798252 Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers Status COMPLETED Phase PHASE1
NCT00797472 Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease Status UNKNOWN Phase PHASE2
NCT00796991 Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine Status COMPLETED Phase PHASE1
NCT00793897 Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00792558 Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers Status WITHDRAWN Phase PHASE1
NCT00790010 Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma Status COMPLETED Phase PHASE1